Item  9.01 Financial Statements and Exhibits.

 

  (d)   Exhibits

 

Exhibit

  

Description

99.1    Press release issued by APP Pharmaceuticals, Inc., Dated August 1, 2008.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

APP PHARMACEUTICALS, INC.
By:  

/s/    Richard J. Tajak

 

Richard J. Tajak

Chief Financial Officer

Date: August 1, 2008